Biosystemix

Biosystemix Joins PRIVAC Program as an Innovative Technology Partner to Enhance the Development and Delivery of Clinical VaccinesFunded by donations from Génome Québec and the private sector, the PRIVAC project, "Genomics Applied to the Discovery and Development of Vaccines and Immunotherapies," unites leading experts, institutions, and commercial efforts. The application of state-of-the-art genomic molecular profiling and computational analysis technology platforms will bring together the components necessary for more effective vaccine development. The biomedical technologies created and applied here will have a significant impact on HIV and cancer vaccine therapies and will lay the groundwork for personalized vaccine treatments for various infectious and immune diseases. Biosystemix will leverage its data-driven approach and pioneering expertise in personalized molecular medicine to rapidly translate clinical science data into commercial biomedical applications.